Jane M. Liebschutz, MD, MPH

Associate Professor, Medicine

Jane Liebschutz
(617) 414-3846
801 Massachusetts Ave Crosstown Center


Trained in internal medicine and preventive medicine, Dr. Liebschutz is a primary care physician, substance use researcher, educator, and administrator. She is the Associate Chief for Faculty Affairs, Section of General Internal Medicine. She is the Director of the combined General Internal Medicine-Family Medicine and General Pediatrics Academic Fellowship. She is also Wellness Director for Boston Medical Center.

Dr. Liebschutz’s research agenda focuses on the intersection of substance use, violence, and mental health within the practice of general medical care. She has conducted observational and intervention studies with opioid prescribing for chronic pain in primary care, including a R01 study examining implementation of the Chronic Care Model. This included developing a nationally recognized website, www.mytopcare.org, with tools for opioid prescribing in primary care. She has also conducted randomized trials for treatment of opioid and injection drug use disorders of hospitalized patients linking to treatment or conducting behavioral interventions to reduce medical complications. She has co-led a 25-year birth cohort to examine young adult outcomes after prenatal cocaine exposure. She uses both qualitative and quantitative research methods, including implementation science, epidemiology, and health services research methods. Her early career focused heavily on violence and health impacts, and she continues to bring those themes into her current work on substance use disorder.

Her research and educational endeavors have been supported by the National Institutes of Health- National Institute on Drug Abuse (NIDA), Health Resources and Services Administration, the Robert Wood Johnson foundation, the American Cancer Society, Substance Abuse and Mental Health Services Administration, and the Agency for Healthcare Quality and Research.

She has mentored dozens of rising health professionals and researchers, from undergraduates to junior faculty. One of her areas of focus is on self-care and wellness. In her role as Wellness Director for Boston Medical Center Medical-Dental Staff, she has initiated various programs, including a wellness website, www.bumc.bu.edu/wellness. She has also focused on the impact of race on clinician and academic faculty.

Other Positions

  • Associate Professor, Community Health Sciences, Boston University School of Public Health
  • Active Staff Hospital Privileges, Medicine, Boston Medical Center


  • Harvard University, MD
  • Yale University, BA


  • Published on 11/1/2017

    Phillips KT, Anderson BJ, Herman DS, Liebschutz JM, Stein MD. Risk Factors Associated With Skin and Soft Tissue Infections Among Hospitalized People Who Inject Drugs. J Addict Med. 2017 Nov/Dec; 11(6):461-467. PMID: 28767536.

    Read at: PubMed
  • Published on 9/1/2017

    Liebschutz JM, Xuan Z, Shanahan CW, LaRochelle M, Keosaian J, Beers D, Guara G, O'Connor K, Alford DP, Parker V, Weiss RD, Samet JH, Crosson J, Cushman PA, Lasser KE. Improving Adherence to Long-term Opioid Therapy Guidelines to Reduce Opioid Misuse in Primary Care: A Cluster-Randomized Clinical Trial. JAMA Intern Med. 2017 Sep 01; 177(9):1265-1272. PMID: 28715535.

    Read at: PubMed
  • Published on 4/10/2017

    Cushman PA, Liebschutz JM, Hodgkin JG, Shanahan CW, White JL, Hardesty I, Alford DP. What do providers want to know about opioid prescribing? A qualitative analysis of their questions. Subst Abus. 2017 Apr-Jun; 38(2):222-229. PMID: 28394736.

    Read at: PubMed
  • Published on 3/31/2017

    Washington DM, Paasche-Orlow MK, Liebschutz JM. Promoting Progress or Propagating Problems: Strategic Plans and the Advancement of Academic Faculty Diversity in U.S. Medical Schools. J Natl Med Assoc. 2017 Summer; 109(2):72-78. PMID: 28599759.

    Read at: PubMed
  • Published on 3/21/2017

    Lee CS, Liebschutz JM, Anderson BJ, Stein MD. Hospitalized opioid-dependent patients: Exploring predictors of buprenorphine treatment entry and retention after discharge. Am J Addict. 2017 Oct; 26(7):667-672. PMID: 28324627.

    Read at: PubMed
  • Published on 12/13/2016

    Gardiner P, Lestoquoy AS, Gergen-Barnett K, Penti B, White LF, Saper R, Fredman L, Stillman S, Lily Negash N, Adelstein P, Brackup I, Farrell-Riley C, Kabbara K, Laird L, Mitchell S, Bickmore T, Shamekhi A, Liebschutz JM. Design of the integrative medical group visits randomized control trial for underserved patients with chronic pain and depression. Contemp Clin Trials. 2017 Mar; 54:25-35. PMID: 27979754.

    Read at: PubMed
  • Published on 9/6/2016

    Larochelle MR, Liebschutz JM, Zhang F, Ross-Degnan D, Wharam JF. Opioid Prescribing After Nonfatal Overdose and Association With Repeated Overdose. Ann Intern Med. 2016 Sep 06; 165(5):376-7. PMID: 27595218.

    Read at: PubMed
  • Published on 7/18/2016

    Lunze K, Raj A, Cheng DM, Quinn EK, Lunze FI, Liebschutz JM, Bridden C, Walley AY, Blokhina E, Krupitsky E, Samet JH. Sexual violence from police and HIV risk behaviours among HIV-positive women who inject drugs in St. Petersburg, Russia - a mixed methods study. J Int AIDS Soc. 2016; 19(4 Suppl 3):20877. PMID: 27435712.

    Read at: PubMed
  • Published on 7/1/2016

    Penti B, Liebschutz JM, Kopcza B, Xuan Z, Odell C, Saper R. Novel peer review method for improving controlled substance prescribing in primary care. J Opioid Manag. 2016 Jul-Aug; 12(4):269-79. PMID: 27575828.

    Read at: PubMed
  • Published on 6/27/2016

    Tsui JI, Lira MC, Cheng DM, Winter MR, Alford DP, Liebschutz JM, Edwards RR, Samet JH. Chronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy. Drug Alcohol Depend. 2016 Sep 01; 166:26-31. PMID: 27422763.

    Read at: PubMed

View 57 more publications: View full profile at BUMC

View all profiles